Bakker Juliet Tammenoms Rx Sight, Inc. (RXST) insider trading activity

Bakker Juliet Tammenoms is of RxSight, Inc.. Currently has a direct ownership of 34,840 shares of RXST, which is worth approximately $2.04 Million. The most recent transaction as insider was on May 17, 2024, when has been sold 5,000 shares (Common Stock) at a price of $61.09 per share, resulting in proceeds of $305,450. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.8K

16.76% 3M change

48.44% 12M change

Total Value Held $2.04 Million

Bakker Juliet Tammenoms Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 17 2024	BUY Open market or private purchase	$305,450 $61.09 p/Share	5,000 Added 12.55%	34,840 Common Stock
Feb 14 2024	BUY Open market or private purchase	$205,160 $51.29 p/Share	4,000 Added 11.82%	29,840 Common Stock
Feb 12 2024	BUY Open market or private purchase	$201,520 $50.38 p/Share	4,000 Added 13.4%	25,840 Common Stock
Nov 30 2023	BUY Other acquisition or disposition	-	1,617 Added 6.89%	21,840 Common Stock
Sep 11 2023	SELL Open market or private sale	$88,529 $30.01 p/Share	2,950 Reduced 12.73%	20,223 Common Stock
Sep 08 2023	SELL Open market or private sale	$303,498 $30.25 p/Share	10,033 Reduced 30.21%	23,173 Common Stock
Sep 07 2023	SELL Open market or private sale	$601,006 $30.1 p/Share	19,967 Reduced 37.55%	33,206 Common Stock

Aug 25 2023	SELL Open market or private sale	$474,084 $29.25 p/Share	16,208 Reduced 23.36%	53,173 Common Stock
Aug 24 2023	BUY Other acquisition or disposition	-	970 Added 1.38%	69,381 Common Stock
Aug 18 2023	SELL Open market or private sale	$425,904 $29.07 p/Share	14,651 Reduced 17.64%	68,411 Common Stock
Aug 17 2023	SELL Open market or private sale	$555,629 $30.06 p/Share	18,484 Reduced 18.2%	83,062 Common Stock
Aug 09 2023	BUY Other acquisition or disposition	-	32,950 Added 24.5%	101,546 Common Stock
Jun 14 2023	BUY Other acquisition or disposition	-	1,022 Added 1.47%	68,596 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	-	5,731 Added 7.82%	67,574 Common Stock
May 26 2023	BUY Other acquisition or disposition	-	33,135 Added 34.89%	61,843 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	10,349 Added 26.5%	28,708 Common Stock
Aug 03 2021	BUY Open market or private purchase	$200,000 $16.0 p/Share	12,500 Added 40.51%	18,359 Common Stock
Jul 30 2021	BUY Grant, award, or other acquisition	-	5,859 Added 50.0%	5,859 Common Stock

Also insider at

EAR

Eargo, Inc. Healthcare

Director

BJT